Patterns of regional failure in stage III non-small cell lung cancer treated with neoadjuvant chemoradiation therapy and resection  Shalini Garg, MD,

Slides:



Advertisements
Similar presentations
Neutron radiation therapy for advanced thyroid cancers Tobias R. Chapman, MD, George E. Laramore, PhD, MD, Stephen R. Bowen, PhD, Peter F. Orio, DO, MS.
Advertisements

Development of a standard survivorship care plan template for radiation oncologists Ronald C. Chen, MD, MPH, Karen E. Hoffman, MD, David J. Sher, MD, MPH,
Su K. Metcalfe, MD, MPH, Michael T
Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the.
Higher Biologically Effective Dose of Radiotherapy Is Associated With Improved Outcomes for Locally Advanced Non–Small Cell Lung Carcinoma Treated With.
Split-Course Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer: A Single-Institution Experience of 144 Patients  Benjamin T. Gielda, MD,
Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)  Neal E. Dunlap,
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,
Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the.
Volume 13, Issue 12, Pages (December 2012)
Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L
RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1- 3) spine metastases: Phase 2 results  Samuel Ryu, MD, Stephanie L.
Jennifer C. Ho, MD, Quynh-Nhu Nguyen, MD, Heng Li, PhD, Pamela K
One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.
Disparities in Treatment of Patients with Inoperable Stage I Non–Small Cell Lung Cancer: A Population-Based Analysis  Matthew Koshy, MD, Renuka Malik,
Split-Course Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer: A Single-Institution Experience of 144 Patients  Benjamin T. Gielda, MD,
Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D
Enhancing the role of case-oriented peer review to improve quality and safety in radiation oncology: Executive summary  Lawrence B. Marks, MD, Robert.
Luiz H. Araujo, MD, MSc, Philip E
Irinotecan-Cisplatin Therapy for Patients with Extensive-Stage Small Cell Lung Cancer: Use Patterns among American Medical Oncologists 2000–2006  Mark.
Dosimetric comparison of 3-dimensional conformal radiation therapy and intensity modulated radiation therapy and impact of setup errors in lower limb.
Matthew J. Boyer, MD, PhD, Christina D. Williams, PhD, MPH, David H
Brian N. Arnold, MD, Daniel C. Thomas, MD, MPH, Joshua E
A Phase II Study of Concurrent Carboplatin and Paclitaxel and Thoracic Radiotherapy for Completely Resected Stage II and IIIA Non-small Cell Lung Cancer 
Impact of radiotherapy dose on dentition breakdown in head and neck cancer patients  Mary P. Walker, DDS, PhD, Brian Wichman, MS, An-Lin Cheng, PhD, James.
The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer  Peter Goldstraw, MB, FRCS, John J. Crowley, PhD 
Pretreatment Anemia Portends Poor Survival and Nonlocal Disease Progression in Patients with Stage I Non–Small Cell Lung Cancer Treated with Stereotactic.
Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K
Volume 13, Issue 12, Pages (December 2012)
American Society for Radiation Oncology's Performance Assessment for the Advancement of Radiation Oncology Treatment: A practical approach for informing.
Stereotactic body radiation therapy and 3-dimensional conformal radiotherapy for stage I non-small cell lung cancer: A pooled analysis of biological equivalent.
Intratumoral Lymphatic Vessel Involvement is an Invasive Indicator of Completely Resected Pathologic Stage I Non-small Cell Lung Cancer  Masahiko Harada,
Survival Benefit of Surgery after Chemoradiotherapy for Stage III (N0–2) Non-Small-Cell Lung Cancer Is Dependent on Pathologic Nodal Response  Ellis Ziel,
Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database  Laura C. Caprario, MD, MS,
ITV-Based Robust Optimization for VMAT Planning of Stereotactic Body Radiation Therapy of Lung Cancer  Xiaoying Liang, PhD, Dandan Zheng, PhD, Maria Mamalui-Hunter,
Defining Optimal Comorbidity Measures for Patients With Early-Stage Non-small cell lung cancer Treated With Stereotactic Body Radiation Therapy  Todd.
The Addition of Chemotherapy to Radiation Therapy Improves Survival in Elderly Patients with Stage III Non–Small Cell Lung Cancer  Eric D. Miller, MD,
Elizabeth B. Gottlin, PhD, Rex C. Bentley, MD, Michael J
Concurrent chemotherapy and intensity modulated radiation therapy in the treatment of anal cancer: A retrospective review from a large academic center 
Yang Zhang, MD, Haiquan Chen, MD, PhD 
A Phase II Study of Paclitaxel + Etoposide + Cisplatin + Concurrent Radiation Therapy for Previously Untreated Limited Stage Small Cell Lung Cancer (E2596):
Effect of Daily and Every Other Day Stereotactic Body Radiation Therapy Schedules on Treatment-Related Fatigue in Patients With Hepatocellular Carcinoma 
An Editorial Note: The Long Arm of Practical Radiation Oncology
The role of positron emission tomography for non-small cell lung cancer  Albert J. Chang, MD, PhD, Farrokh Dehdashti, MD, Jeffrey D. Bradley, MD  Practical.
Volume 155, Issue 1, Pages (January 2019)
Ronald C. Chen, MD, MPH, Karen E. Hoffman, MD, David J
Burnout and Resiliency in Canadian Oncology Residents: A Nationwide Resident and Program Director Survey  Hannah Dahn, MD, Angela McGibbon, MD, David.
Daniel Morgensztern, MD, Boone Goodgame, MD, Maria Q
Implementation of hypofractionated prostate radiation therapy in the United States: A National Cancer Database analysis  William A. Stokes, MD, Brian.
Positron Emission Tomography 18F-Fluorodeoxyglucose Uptake and Prognosis in Patients with Surgically Treated, Stage I Non-small Cell Lung Cancer: A Systematic.
Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey  Daniel Morgensztern, MD, Shean Huey Ng,
Definition of medical event is to be based on the total source strength for evaluation of permanent prostate brachytherapy: A report from the American.
Stereotactic Body Radiation Therapy for the Treatment of Primary Cardiac Angiosarcoma Causing Hemodynamic Instability  Prashant Gabani, MD, Benjamin W.
Jie Huang, Juan Peng, Linlang Guo, MD, PhD 
Genetic Changes in Squamous Cell Lung Cancer: A Review
International Thymic Malignancies Interest Group: A Way Forward
740. Prevention of Radiation-Induced Lung Injury by Administration of Gene-Modified Mesenchymal Stem Cells    Molecular Therapy  Volume 20, Pages S285-S286.
Impact of Tumor Size on Local Control and Pneumonitis After Stereotactic Body Radiation Therapy for Lung Tumors  Sean M. Parker, BS, R. Alfredo Siochi,
Stage I Non-small Cell Lung Cancer: Results for Surgery in a Patterns-of-Care Study in Sydney and for High-Dose Concurrent End-Phase Boost Accelerated.
Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer  Pamela Samson, MD,
Adjuvant and Salvage Radiation Therapy After Prostatectomy: ASTRO/AUA Guideline Amendment, Executive Summary 2018  Thomas M. Pisansky, MD, Ian M. Thompson,
Wedge Resection for Non-small Cell Lung Cancer in Patients with Pulmonary Insufficiency: Prospective Ten-Year Survival  John P. Griffin, MD, Charles E.
Pneumonectomy After Chemoradiation Therapy for Non-Small Cell Lung Cancer: Does “Side” Really Matter?  Anthony W. Kim, MD, L. Penfield Faber, MD, William.
Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)  Neal E. Dunlap,
Induction Therapy For Locally Advanced Thymoma
Manisha Palta, MD, Devon Godfrey, PhD, Karyn A
Benjamin D. Kozower, MD, MPH, Shubin Sheng, PhD, Sean M
A Review of First-Line Treatment for Small-cell Lung Cancer
Long-Term Follow-Up of a Phase I/II Trial of Dose Escalating Three-Dimensional Conformal Thoracic Radiation Therapy with Induction and Concurrent Carboplatin.
Presentation transcript:

Patterns of regional failure in stage III non-small cell lung cancer treated with neoadjuvant chemoradiation therapy and resection  Shalini Garg, MD, Benjamin T. Gielda, MD, Julius V. Turian, PhD, Michael Liptay, MD, William H. Warren, MD, Philip Bonomi, MD, David J. Sher, MD, MPH  Practical Radiation Oncology  Volume 3, Issue 4, Pages 287-293 (October 2013) DOI: 10.1016/j.prro.2012.09.002 Copyright © 2013 American Society for Radiation Oncology Terms and Conditions

Figure 1 Pattern of first failure. Practical Radiation Oncology 2013 3, 287-293DOI: (10.1016/j.prro.2012.09.002) Copyright © 2013 American Society for Radiation Oncology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.